Senegal vs Zimbabwe: Antiretroviral therapy coverage for PMTCT
Senegal
94.0%
in 2024
Zimbabwe
93.0%
in 2024
Senegal rank
18th
Zimbabwe rank
20th
Antiretroviral therapy coverage for PMTCT over time
- Senegal
- Zimbabwe
How they compare
Senegal currently reports 94.0% against 93.0% in Zimbabwe, a difference of 1.0%.
The two have swapped places 3 times across 25 shared years of data; in 2000 it was Zimbabwe ahead.
Senegal ranks 18th and Zimbabwe ranks 20th of 84 countries.
Across the 3 decades both report, Senegal averaged higher in 1 and Zimbabwe in 2.
Head to head by decade
| Decade | Senegal | Zimbabwe | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 8.8% | 14.2% | 5.4% | Zimbabwe |
| 2010s | 67.4% | 75.3% | 7.9% | Zimbabwe |
| 2020s | 96.6% | 89.4% | 7.2% | Senegal |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher antiretroviral therapy coverage for pmtct, Senegal or Zimbabwe?
- Senegal, at 94.0% against 93.0% in Zimbabwe as of 2024.
- What is the difference in antiretroviral therapy coverage for pmtct between Senegal and Zimbabwe?
- 1.0%, with Senegal ahead.
- How many years of comparable data are there for Senegal and Zimbabwe?
- 25 years are reported by both, from 2000 to 2024.
- How do Senegal and Zimbabwe rank globally for antiretroviral therapy coverage for pmtct?
- Senegal ranks 18th and Zimbabwe ranks 20th of 84 countries.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).